Pharmaceutical services companies and CROs now find themselves as members of the knowledge economy. Where the nature of work is not only information-based, but also consistently nonlinear, only partially predictable, networked, interdependent, and increasingly collaborative - it takes partnerships with payers, providers, patients and other new players in the healthcare delivery system (e.g. think Google or Apple) to succeed. To this end, any successful business in this new knowledge economy must adopt data and information as their currency and look there for innovation and competitive advantage. Today and tomorrow’s advances in artificial intelligence and related advanced automation tools provide a key to unlock productivity and fundamentally help the industry in its journey from volume to value, where access to information, and the utility of technology and evidence continue to drive increased nuance and opportunity for innovators. This is especially true for those looking to improve patient outcomes and medicinal value by capitalizing on the accelerated pace of technology democratization, and the increasing volume, variety and velocity of information (e.g. biomarker discovery tools, AI-everything, etc.). Understanding how and when to engage in the frenzy can be daunting. The goal of this panel is discuss and share how these enabling technologies are already helping today and in what context.